Alzheimer's testing today is bottlenecked around the onset of symptoms, when the damage is already done. Current treatments, including the FDA-approved drugs released in 2024, don't reverse the disease; they only slow it down. Earlier detection means earlier intervention.

Eye movement changes linked to Alzheimer's surface sooner than any other biomarker, up to 15 years before symptoms appear.

We deliver a 15-minute VR assessment delivered to patients in longevity clinics:
• Tasks: patients perform visual tasks designed by neurologists to trigger a distinct oculomotor response in people

Hard Tech · Hardware · Machine Learning · B2B · Healthcare

spotted on YC Startup Directory